CTCA is proud to share the expertise of our physicians through a series of free CME education, both virtual and live. Driven by the goal of improving patient care, our CME program is dedicated to providing a robust, well-rounded portfolio of CME activities that contribute to the greater good of our clinical communities.
Despite disparities in health care quality, outcomes, complications, excess disease burden, and premature death rates in cancer (in addition to a many other illnesses) being well documented, little progress has been done in reducing them. Even when physicians and health professionals are aware of such disparities, they may be unaware the effect on their own patients and what they can do to help to address such disparities.
In a 3-part series, CTCA leaders Anita Johnson and Chevon Rariy join other leaders in the medical arena to discuss the health disparities within cancer care, uncover some of the hurdles to providing better care, and expound on how health systems, communities, and larger healthcare ecosystem can empower patients, providers, payors, and others to build trust, provide access, and discuss evidence-based practices and strategies to help reduce disparities in health care and advance health equity in cancer care.
After participating in this 3-part series, learners will be able to:
Faculty:
Available Dates:
The Specialty CME Series is designed to provide oncologists, primary care providers or other specialists with the latest information, data, best practices, recommendations and guidelines for treating cancer patients. In this episode of the series, Syed A. Abutalib, MD, will discuss the management of patients with COVID-19 infections and hematologic disturbances.
After participating in this education, learners will be able to:
Faculty:
CME Forum is an educational event designed to foster dialog between primary care providers (PCPs) and the oncology team, providing strategies that contribute to integrative care for patients with cancer. Recordings of presentations, case studies and Q & A sessions are available on demand or as live webinars to enhance clinician knowledge and competence. Click on the registration links to learn more about topics and faculty for each on demand event.
Available Dates:
Part I
Part II
Part III
Part IV
Part V
A multidisciplinary team discusses treatment options for cancer patients in a tumor board format based on data collected from patients, such as, genetic/genomic testing, pathology and radiological imaging. Cases discussed include: gallbladder carcinoma, triple negative breast cancer, endometrial cancer and adenocarcinoma of unknown primary.
Upon completion of this activity, participants will be able to:
Faculty:
Available Dates:
Part I
Part II
Part III
This educational activity is designed to educate clinicians such as oncologists and gastroenterologists as well as physician-trainees, pharmacists, nurses and allied health professionals involved in the care and management of patients suffering from rectal cancer. In recent years, the average age of patients with rectal cancer has decreased. These younger patients require different treatment approaches. This activity is focused on sharing the various protocols for managing rectal cancer in young adults, focusing on how recommendations differ in a younger population, and emerging evidence of the effectiveness of various approaches in patients under 50.
Upon completion of this activity, participants will be able to:
Faculty:
COVID-19 changed the landscape for many healthcare providers. In addition to creating a need for appointments with minimal contact, the Centers for Medicare and Medicaid relaxed and modified policy surrounding telehealth appointments to facilitate quick transition to virtual appointments. This education will share best practices and compliance considerations for deploying a pandemic response telehealth program, and recommendations for transitioning this program to a post-COVID world.
Upon completion of this activity, participants will be able to:
Faculty:
Lymphedema is a common side effect in patients with cancer. While surgical interventions may sometimes be necessary, there are many less invasive options as well which may effectively manage the condition for some patients. This program aims to discuss the latest data on methods of managing lymphedema, and how to determine which method is best for each patient.
Upon completion of this activity, participants will be able to:
Faculty:
Clinicians require education surrounding lung nodules and need to be updated on new and emerging therapies that will lead to individualized treatment and improved outcomes. As technology improves and new data emerges, recommendations for how and when to follow up with patients with lung nodules continues to evolve. This activity provides a platform to understand the latest guidance.
Upon completion of this activity, participants will be able to:
Faculty: